| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
|---|---|---|---|---|---|---|
| 2011 | Carbamazepine-induced toxic effects and HLA-B*1502 screening in Taiwan | PEI-JER CHEN ; Lin J.-J.; Lu C.-S.; Ong C.-T.; Hsieh P.F.; Yang C.-C.; Tai C.-T.; Wu S.-L.; Lu C.-H.; Hsu Y.-C.; Yu H.-Y.; Ro L.-S.; Lu C.-T.; Chu C.-C.; Tsai J.-J.; Su Y.-H.; Lan S.-H.; Sung S.-F.; Lin S.-Y.; Chuang H.-P.; Huang L.-C.; Chen Y.-J.; Tsai P.-J.; Liao H.-T.; Lin Y.-H.; Chen C.-H.; Chung W.-H.; Hung S.-I.; Wu J.-Y.; Chang C.-F.; Chen L.; Chen Y.-T.; Shen C.-Y. | New England Journal of Medicine | 544 | 478 | |
| 2008 | Comparison of two PCR-based molecular methods in the diagnosis of CMT 1A and HNPP diseases in Chinese | Chen S.-R.; Lin K.-P.; Kuo H.-C.; Chen C.-M.; SUNG-TSANG HSIEH ; MING-JEN LEE ; Yang C.-C.; Liu C.-S.; Huang C.-C.; Lyu R.-K.; Ro L.-S. | Clinical Neurology and Neurosurgery | 7 | 5 | |
| 2021 | Epidemiology, treatment patterns and healthcare utilizations in multiple sclerosis in Taiwan | Hsu C.-Y.; Ro L.-S.; Chen L.-J.; Chang C.-W.; Chang K.-H.; Wu I.-H.; Lin A.; FEI-YUAN HSIAO | Scientific Reports | 1 | 1 | |
| 2021 | Real-world evidence on the safety and effectiveness of fingolimod in patients with multiple sclerosis from Taiwan | Yang C.-C.; Ro L.-S.; Tsai N.-W.; Lin C.-C.; Huang W.-N.; Tsai C.-P.; Lin T.-S.; JEN-JEN SU ; Huang C.-C.; Lyu R.-K.; Chen H.-H.; Lee W.-J.; Chen P.-L.; Yang A. | Journal of the Formosan Medical Association | 6 | 3 |
